References
- Bush, K. 2001. New beta-lactamases in Gram-negative bacteria: diversity and impact on the selection of antimicrobial therapy. Clin. Infect. Dis. 32, 1085-1089 https://doi.org/10.1086/319610
-
Castanheira, M., M.A. Toleman, R.N. Jones, F.J. Schmidt, and T.R. Walsh. 2004. Molecular characterization of a
$\beta$ -lactamase gene, blaGIM-1, encoding a new subclass of metallo-$\beta$ -lactamase. Antimicrob. Agents Chemother. 48, 4654-4661 https://doi.org/10.1128/AAC.48.12.4654-4661.2004 - Clinical and Laboratory Standards Institute. 2006. Performance standards for antimicrobial susceptibility testing, 16th informational supplement, M100-S16. Clinical and Laboratory Standards Institute, Wayne, Pa, USA
- Falagas, M.E. and I.A. Bliziotis. 2007. Pandrug-resistant Gram-negative bacteria: the dawn of the post-antibiotic era? Int. J. Antimicrob. Agents 29, 630-636 https://doi.org/10.1016/j.ijantimicag.2006.12.012
- Falagas, M.E., I.A. Bliziotis, S.K. Kasiakou, G. Samonis, P. Athanassopoulou, and A. Michalopoulos. 2005. Outcome of infections due to pandrug-resistant (PDR) Gram-negative bacteria. BMC Infect. Dis. 5, 24-30 https://doi.org/10.1186/1471-2334-5-24
- Gales, A.C., R.N. Jones, and H.S. Sader. 2006. Global assessment of the antimicrobial activity of polymyxin B against 54,731 clinical isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001-2004). Clin. Microbiol. Infect. 12, 315-321 https://doi.org/10.1111/j.1469-0691.2005.01351.x
- Giamarellos-Bourboulis, E.J., H. Sambatakou, I. Galani, and H. Giamarellou. 2003. In vitro interaction of colistin and rifampin on multidrug-resistant Pseudomonas aeruginosa. J. Chemother. 15, 235-238 https://doi.org/10.1159/000069498
- Grundmann, H., C. Schneider, D. Hartung, F.D. Daschner, and T.L. Pitt. 1995. Discriminatory power of three DNA-based typing techniques for Pseudomonas aeruginosa. J. Clin. Microbiol. 33, 528-534
- Hancock, R.E. 1998. Resistance mechanisms in Pseudomonas aeruginosa and other nonfermentative Gram-negative bacteria. Clin. Infect. Dis. 27 (Suppl. 1), S93-S99 https://doi.org/10.1086/514612
- Jarvis, W.R. and W.J. Martone. 1992. Predominant pathogens in hospital infections. J. Antimicrob. Chemother. 29 (Suppl. A), 19-24 https://doi.org/10.1093/jac/29.1.19
-
Jeon, B.C., S.H. Jeong, I.K. Bae, S.B. Kwon, K. Lee, D. Young, J.H. Lee, J.S. Song, and S.H. Lee. 2005. Investigation of a nosocomial outbreak of imipenem-resistant Acinetobacter baumannii producing OXA-23
$\beta$ -lactamase in Korea. J. Clin. Microbiol. 43, 2241-2245 https://doi.org/10.1128/JCM.43.5.2241-2245.2005 -
Lagatolla, C., E. Edalucci, L. Dolzani, M.L. Riccio, F. De Luca, E. Medessi, G.M. Rossolini, and E.A. Tonin. 2006. Molecular evolution of metallo-
$\beta$ -lactamase-producing Pseudomonas aeruginosa in a nosocomial setting of high-level endemicity. J. Clin. Microbiol. 44, 2348-2353 https://doi.org/10.1128/JCM.00258-06 - Landman, D., S. Bratu, M. Alam, and J. Quale. 2005. Citywide emergence of Pseudomonas aeruginosa strains with reduced susceptibility to polymyxin B. J. Antimicrob. Chemother. 55, 954-957 https://doi.org/10.1093/jac/dki153
- Lee, J.H., C.H. Choi, H.Y. Kang, J.Y. Lee, J. Kim, Y.C. Lee, S.Y. Seol, D.T. Cho, K.W. Kim, D.Y. Song, and J.C. Lee. 2007. Differences in phenotypic and genotypic traits against antimicrobial agents between Acinetobacter baumannii and Acinetobacter genomic species 13TU. J. Antimicrob. Chemother. 59, 633-639 https://doi.org/10.1093/jac/dkm007
-
Lee, K., Y. Chong, H.B. Shin, Y.A. Kim, D. Yong, and J.H. Yum. 2001. Modified Hodge and EDTA-disk synergy tests to screen metallo-
$\beta$ -lactamase-producing strains of Pseudomonas and Acinetobacter species. Clin. Microbiol. Infect. 7, 88-91 https://doi.org/10.1046/j.1469-0691.2001.00204.x -
Lee, K., J.H. Yum, D. Yong, H.M. Lee, H.D. Kim, J.D. Docquier, G.M. Rossolini, and Y. Chong. 2005. Novel acquired metallo-
$\beta$ -lactamase gene, blaSIM-1, in a class 1 integron from Acinetobacter baumannii clinical isolates from Korea. Antimicrob. Agents Chemother. 49, 4485-4491 https://doi.org/10.1128/AAC.49.11.4485-4491.2005 -
Livermore, D.M. 1995.
$\beta$ -Lactamase in laboratory and clinical resistance. Clin. Microb. Rew. 8, 557-584 - Livermore, D.M. 2001. Of Pseudomonas, porins, pumps and carbapenems. J. Antimicrob. Chemother. 47, 247-250 https://doi.org/10.1093/jac/47.3.247
-
Murphy, T.A., A.M. Simm, M.A. Toleman, R.N. Jones, and T.R. Walsh. 2003. Biochemical characterization of the acquired metallo-
$\beta$ -lactamase SPM-1 from Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 47, 582-587 https://doi.org/10.1128/AAC.47.2.582-587.2003 -
Oh, E.J., S. Lee, Y.J. Park, J.J. Park, K. Park, S.I. Kim, M.W. Kang, and B.K. Kim. 2003. Prevalence of metallo-
$\beta$ -lactamase among Pseudomonas aeruginosa and Acinetobacter baumannii in a Korean University Hospital and comparison of screening methods for detecting metallo-$\beta$ -lactamase. J. Microbiol. Methods 54, 411-418 https://doi.org/10.1016/S0167-7012(03)00090-3 - Ohara, M., S. Kouda, M. Onodera, Y. Fujiue, M. Sasaki, T. Kohara, S. Kashiyama, S. Hayashida, M. Kadono, H. Komatsuzawa, N. Gotoh, T. Usui, H. Itaha, M. Kuwabara, T. Yokoyama, and M. Sugai. 2007. Molecular characterization of imipenem-resistant Pseudomonas aeruginosa in Hiroshima, Japan. Microbiol. Immunol. 51, 271-277 https://doi.org/10.1111/j.1348-0421.2007.tb03908.x
-
Poirel, L., T. Lambert, S. Turkoglu, E. Ronco, J. Gaillard, and P. Nordmann. 2001. Characterization of class 1 integrons from Pseudomonas aeruginosa that contain the blaVIM-2 carbapenemhydrolyzing
$\beta$ -lactamase gene and of two novel aminoglycoside resistance gene cassettes. Antimicrob. Agents Chemother. 45, 546-552 https://doi.org/10.1128/AAC.45.2.546-552.2001 -
Poirel, L., T. Naas, D. Nicolas, L. Collet, S. Bellais, J.D. Cavallo, and P. Nordmann. 2000. Characterization of VIM-2, a carbapenem- hydrolyzing metallo-
$\beta$ -lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob. Agents Chemother. 44, 891-897 https://doi.org/10.1128/AAC.44.4.891-897.2000 - Poirel, L. and P. Nordmann. 2006. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin. Microbiol. Infect. 12, 826-836 https://doi.org/10.1111/j.1469-0691.2006.01456.x
-
Rasmussen, B.A. and K. Bush. 1997. Carbapenem-hydrolyzing
$\beta$ -lactamases. Antimicrob. Agents Chemother. 41, 223-232 - Rossolini, G.M. and E. Mantengoli. 2005. Treatment and control of severe infections caused by multiresistant Pseudomonas aeruginosa. Clin. Microbiol. Infect. 11 (Suppl. 4), 17-32
- Tenover, F.C., R.D. Arbeit, R.V. Goering, P.A. Mickelsen, B.E. Murray, D.H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsedfield gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33, 2233-2239
-
Yong, D., Y.S. Choi, K.H. Roh, C.K. Kim, Y.H. Park, J.H. Yum, K. Lee, and Y. Chong. 2006. Increasing prevalence and diversity of metallo-
$\beta$ -lactamases in Pseudomonas spp., Acinetobacter spp., and Enterobacteriaceae from Korea. Antimicrob. Agents Chemother. 50, 1884-1886 https://doi.org/10.1128/AAC.50.5.1884-1886.2006